New insights into the mechanism of abnormal calcification in nephrogenic systemic fibrosis - gadolinium promotes calcium deposition of mesenchymal stem cells and dermal fibroblasts

Journal of Dermatological Science

Volumn 62, Issue 1, 2011, Pages 58-63

  Okada, Etsuko ^a   Yamanaka, Masayoshi ^a   Ishikawa, Osamu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcification; Dermal fibroblasts; Gadolinium; Mesenchymal stem cells; Nephrogenic systemic fibrosis

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; GADOLINIUM CHLORIDE; MESSENGER RNA;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FIBROGENESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NEPHROGENIC SYSTEMIC FIBROSIS; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROADIPOCYTE; SKIN CALCIFICATION; SKIN FIBROBLAST;

3T3 CELLS; ADIPOSE TISSUE; ANIMALS; CALCINOSIS; CALCIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSIS; GADOLINIUM; HUMANS; MESENCHYMAL STEM CELLS; MICE; NEPHROGENIC FIBROSING DERMOPATHY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN;

EID: 79952697159     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.01.009     Document Type: Article

References (40)

1. Cowper S.E., Robin H.S., Steinberg S.M., Su L.D., Gupra S., Leboit P.E. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000, 356:1000-1001.
2. Grobner T. Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol. Dial. Transplant. 2006, 21:1104-1108.
3. Schuhmann-Giampieri G., Krestin G. Pharmacokinetics of Gd-DTPA in patients with chronic renal failure. Invest. Radiol. 1991, 26:975-979.
4. Joffe P., Thomsen H.S., Meusel M. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad. Radiol. 1998, 5:491-502.
5. Puttagunta N.R., Gibby W.A., Smith G.T. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Invest. Radiol. 1996, 31:739-742.
6. Sieber M.A., Steger-Hartmann T., Lengsfeld P., Pietsch H. Gadolinium-based contrast agents and nsf: evidence from animal experience. J. Magn. Reson. Imaging 2009, 30:1268-1276.
7. Abraham J.L., Thakral C., Skov L., Rossen K., Marckmann P. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br. J. Dermatol. 2008, 158:273-280.
8. Boyd A.S., Zic J.A., Abraham J.L. Gadolinium deposition in nephrogenic fibrosing dermopathy. J. Am. Acad. Dermatol. 2007, 56:27-30.
9. Wiginton C.D., Kelly B., Oto A., Jesse M., Aristimuno P., Ernst R., et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. Am. J. Roentgenol. 2008, 190:1-9.
10. Nagai Y, Hasegawa M., Shinmi K., Kishi C., Tsushima Y., Endo K., et al. Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia. Acta Derm. Venereol. 2008, 88:597-600.
11. Song J., Volkov S., Shea C.R., Alegre M.L., Salgia R., Gregg K., et al. Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases. J. Cutan. Pathol. 2009, 36:31-34.
12. Edsall L, English J., Teague M., Patterson J.W. Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy. J. Cutan. Pathol. 2004, 31:247-253.
13. Ruiz-Genao D., Pascual-Lopez M., Fraga S., Aragues M., Garcia-Diez A. Osseous metaplasia in the setting of nephrogenic fibrosing dermopathy. J. Cutan. Pathol. 2005, 32:172-175.
14. Ting W.W., Stone S.M., Madison K.C., Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch. Dermatol. 2003, 139:903-906.
15. Hershko K., Hull C., Ettefagh L., Nedorost S., Dyson S., Horn T., et al. A variant of nephrogenic fibrosing dermopathy with osteoclast-like giant cells: a syndrome of deregulated matrix remodeling. J. Cutan. Pathol. 2004, 31:262-265.
16. Swartz R.D., Crofford L.J., Phan S.H., Ike R.W., Su L.D. Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am. J. Med. 2003, 114:563-572.
17. Markus J.S., James A.J., Nunez-Gussman J.K., Sheehan A.M., Fegan L., Hsu S. Nephrogenic fibrosing dermopathy. J. Am. Acad. Dermatol. 2005, 52:166-167.
18. Lewis K.G., Lester B.W., Pan T.D., Robinson-Boston L. Nephrogenic fibrosing dermopathy and calciphylaxis with pseudoxanthoma elasticum-like changes. J. Cutan. Pathol. 2006, 33:695-700.
19. Cowper S.E., Su L., Robin H., Bhawan J., Leboit P.E. Nephrogenic fibrosing dermopathy. Am. J. Dermatopathol. 2001, 23:383-393.
20. Vattikuti R., Towler D.A. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004, 286:E686-696.
21. Abedin M., Tintut Y., Demer L.L. Vascular calcification mechanisms and clinical ramifications. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1161-1170.
22. Persy V., D'Haese P. Vascular calcification and bone disease: the calcification paradox. Trends Mol. Med. 2009, 15:405-416.
23. Jono S., Shioi A., Ikari Y., Nishizawa Y. Vascular calcification in chronic kidney disease. J. Bone Miner. Metab. 2006, 24:176-181.
24. Sudo H., Kodama H.A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 1983, 96:191-198.
25. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002, 13:4279-4295.
26. Bartsch G., Yoo J.J., De Coppi P., Siddiqui M.M., Schuch G., Pohl H.G., et al. Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev 2005, 14:337-348.
27. Toma J.G, McKenzie I.A., Bagli D., Miller F.D. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005, 23:727-737.
28. Chen F.G., Zhang W.J., Bi D., Liu W., Wei X., Chen F.F., et al. Clonal analysis of nestin-vimentin+ multipotent fibroblasts isolated from human dermis. J. Cell Sci. 2007, 120:2875-2883.
29. Lorenz K., Sicker M., Schmelzer E., Rupf T., Salvetter J., Schulz-Siegmund M., et al. Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp. Dermatol. 2008, 17:925-932.
30. Ortonne N., Lipsker D., Chantrel F., Boehm N., Grosshans E., Cribier B. Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy; a new pathogenic hypothesis. Br. J. Dermatol. 2004, 150:1050-1052.
31. Roufosse C.A., Direkze N.C., Otto W.R., Wright N.A. Circulating mesenchymal stem cells. Int. J. Biochem. Cell Biol. 2004, 36:585-597.
32. Tondreau T., Meuleman N., Delforge A., Dejeneffe M., Leroy R., Massy M., et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005, 23:1105-1112.
33. Brendel C, Kuklick L., Hartmann O., Kim T.D., Boudriot U., Schwell D., et al. Distinct gene expression profile of human mesenchymal stem cells in comparison to skin fibroblasts employing cDNA microarray analysis of 9600 genes. Gene Expr. 2005, 12:245-257.
34. Gregory C.A., Gunn W.G., Peister A., Prockop D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 2004, 329:77-84.
35. Rinehart R.W. Spectrophotometric determination of some rare earths and yttrium with alizarin red S. Anal. Chem. 1954, 26:1820-1822.
36. Bhogal R.K., Stoica C.M., Mcgaha T.L., Bona C.A. Molecular aspects of regulation of collagen gene expression in fibrosis. J. Clin. Immunol. 2005, 25:592-603.
37. Trojanowska M., LeRoy E.C., Eckes B., Krieg T. Pathogenesis of fibrosis: type 1 collagen and the skin. J. Mol. Med. 1998, 76:266-274.
38. Jimenez S.A., Derk C.T. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann. Intern. Med. 2004, 140:37-50.
39. Marneros A.G., Krieg T. Keloids-clinical diagnosis, pathogenesis, and treatment options. J Dtsch Dermatol Ges 2004, 2:905-913.
40. Cowper S.E, Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am. J. Dermatopathol. 2003, 25:358.